AbCellera Biologics(ABCL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABCL AbCellera Biologics

盘后交易 07-22 18:25:54 EDT

3.01

+0.04

+1.35%

盘后2.95

-0.06-1.99%

18:08 EDT

最高3.02	最低2.93	成交量88.50万
今开3.00	昨收2.97	日振幅3.03%
总市值8.85亿	流通市值5.67亿	总股本2.94亿
成交额262.78万	换手率0.47%	流通股本1.88亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABCL","market":"US","secType":"STK","nameCN":"AbCellera Biologics","latestPrice":3.01,"timestamp":1721678400000,"preClose":2.97,"halted":0,"volume":884999,"hourTrading":{"tag":"盘后","latestPrice":2.95,"preClose":3.01,"latestTime":"18:08 EDT","volume":1975,"amount":5947.426915,"timestamp":1721686131733},"delay":0,"floatShares":188281416,"shares":294054356,"eps":-0.510213,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.04,"latestTime":"07-22 18:25:54 EDT","open":3,"high":3.02,"low":2.93,"amount":2627803.2817274,"amplitude":0.030303,"askPrice":3.27,"askSize":100,"bidPrice":2.92,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.510213,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721692800000},"adr":0,"listingDate":1607662800000,"adjPreClose":2.97,"preHourTrading":{"tag":"盘前","latestPrice":3,"preClose":2.97,"latestTime":"09:20 EDT","volume":822,"amount":2469.851892,"timestamp":1721654420439},"postHourTrading":{"tag":"盘后","latestPrice":2.95,"preClose":3.01,"latestTime":"18:08 EDT","volume":1975,"amount":5947.426915,"timestamp":1721686131733},"volumeRatio":0.722014,"impliedVol":6.2536,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/ABCL","defaultTab":"news","newsList":[{"id":"2452943852","title":"Abcellera Biologics Inc.盘中异动 快速跳水5.04%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452943852","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452943852?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:46","pubTimestamp":1721313981,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时46分，Abcellera Biologics Inc.股票出现异动，股价急速下挫5.04%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。借助综合AbCelera平台，公司的专家可以搜索各种不同的抗体，从而快速筛选出有效和可开发的先导药物，帮助合作伙伴取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718224622af92ff6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718224622af92ff6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4121","ABCL"],"gpt_icon":0},{"id":"2451623911","title":"Abcellera Biologics Inc.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451623911","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451623911?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:26","pubTimestamp":1721143600,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时26分，Abcellera Biologics Inc.股票出现异动，股价大幅拉升5.00%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。借助综合AbCelera平台，公司的专家可以搜索各种不同的抗体，从而快速筛选出有效和可开发的先导药物，帮助合作伙伴取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716232640941f77a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716232640941f77a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","ABCL","BK4121","BK4007"],"gpt_icon":1},{"id":"2450368074","title":"Abcellera Biologics Inc.盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450368074","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450368074?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:37","pubTimestamp":1720705029,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时37分，Abcellera Biologics Inc.股票出现异动，股价大幅上涨5.36%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。消息层面，截至21时37分，《KeyBanc维持AbCellera Biologics买入评级，下调目标价至5美元》资讯为影响Abcellera Biologics Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213710af91dd88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213710af91dd88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ABCL","BK4535"],"gpt_icon":0},{"id":"2448103309","title":"Abcellera Biologics Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448103309","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448103309?lang=zh_cn&edition=full","pubTime":"2024-07-02 00:14","pubTimestamp":1719850480,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日00时14分，Abcellera Biologics Inc.股票出现异动，股价大幅下挫5.07%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。AbCelera利用专有硬件、软件和工具以及最新的数据科学，作为战略合作伙伴运营，并帮助更快地为任何项目开发优化的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702001440941f2ca4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702001440941f2ca4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ABCL","BK4535"],"gpt_icon":0},{"id":"2438854377","title":"Abcellera Biologics Inc.盘中异动 早盘急速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438854377","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438854377?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:31","pubTimestamp":1716903112,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时31分，Abcellera Biologics Inc.股票出现波动，股价急速拉升5.19%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.82%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。借助综合AbCelera平台，公司的专家可以搜索各种不同的抗体，从而快速筛选出有效和可开发的先导药物，帮助合作伙伴取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213153af8ab2f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213153af8ab2f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4535","ABCL"],"gpt_icon":0},{"id":"2435259356","title":"Abcellera Biologics Inc.2024财年第一财季实现净利润-40.61百万美元，同比减少1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435259356","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435259356?lang=zh_cn&edition=full","pubTime":"2024-05-13 00:16","pubTimestamp":1715530602,"startTime":"0","endTime":"0","summary":"3月31日，Abcellera Biologics Inc.公布财报，公告显示公司2024财年第一财季净利润为-40.61百万美元，同比减少1.25%；其中营业收入为9.95百万美元，同比减少18.38%，每股基本收益为-0.14美元。从资产负债表来看，Abcellera Biologics Inc.总负债2.23亿美元，其中短期债务5.53百万美元，资产负债比为6.57，流动比率为7.76。机构评级：截至2024年3月31日，当前有8家机构对Abcellera Biologics Inc.目标价做出预测，其中目标均价为14.62美元，其中最低目标价为7.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130016478afe8ff1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130016478afe8ff1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL"],"gpt_icon":0},{"id":"2434779348","title":"Abcellera Biologics Inc.盘中异动 大幅下跌5.20%报3.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434779348","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434779348?lang=zh_cn&edition=full","pubTime":"2024-05-09 00:26","pubTimestamp":1715185574,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日00时26分，Abcellera Biologics Inc.股票出现波动，股价大幅下挫5.20%。截至发稿，该股报3.83美元/股，成交量44.9951万股，换手率0.15%，振幅8.89%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090026157a58c708&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090026157a58c708&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4121","BK4535"],"gpt_icon":0},{"id":"2432908864","title":"Abcellera Biologics Inc.盘中异动 大幅上涨5.19%报4.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432908864","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432908864?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:38","pubTimestamp":1714743522,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时38分，Abcellera Biologics Inc.股票出现异动，股价大幅拉升5.19%。截至发稿，该股报4.05美元/股，成交量13.1494万股，换手率0.04%，振幅3.08%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213842861ead60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213842861ead60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VAXX","BK4535","ABCL","BK4139","BK4121"],"gpt_icon":0},{"id":"2430870762","title":"Abcellera Biologics Inc.盘中异动 快速跳水5.00%报3.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430870762","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430870762?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:52","pubTimestamp":1714056746,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时52分，Abcellera Biologics Inc.股票出现波动，股价急速下跌5.00%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为2.20%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。借助综合AbCelera平台，公司的专家可以搜索各种不同的抗体，从而快速筛选出有效和可开发的先导药物，帮助合作伙伴取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425225226861e91cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425225226861e91cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4535","ABCL"],"gpt_icon":0},{"id":"2429211374","title":"Abcellera Biologics Inc.盘中异动 早盘股价大涨5.24%报4.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429211374","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429211374?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:07","pubTimestamp":1713881272,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时07分，Abcellera Biologics Inc.股票出现波动，股价大幅上涨5.24%。截至发稿，该股报4.22美元/股，成交量23.7681万股，换手率0.08%，振幅4.99%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为1.26%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423220752861e8301&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423220752861e8301&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4121","BK4535"],"gpt_icon":0},{"id":"2426491767","title":"Abcellera Biologics Inc.盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426491767","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426491767?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:31","pubTimestamp":1712755867,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时31分，Abcellera Biologics Inc.股票出现异动，股价大幅下挫5.29%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为1.15%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一种抗体发现和开发引擎，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者。借助集成的 AbCelera 平台，公司的专家搜索范围广泛的不同抗体，以快速选择最有效和可开发的先导物，并建立合作伙伴以取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213108861e4a3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213108861e4a3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4121","BK4535"],"gpt_icon":0},{"id":"2426118041","title":"Abcellera Biologics Inc.盘中异动 急速上涨5.01%报4.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426118041","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426118041?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:10","pubTimestamp":1712671833,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时10分，Abcellera Biologics Inc.股票出现波动，股价快速拉升5.01%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一种抗体发现和开发引擎，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者。借助集成的 AbCelera 平台，公司的专家搜索范围广泛的不同抗体，以快速选择最有效和可开发的先导物，并建立合作伙伴以取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092210337a51a729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092210337a51a729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4121","ABCL"],"gpt_icon":0},{"id":"2422064766","title":"Abcellera Biologics Inc.盘中异动 大幅下挫5.02%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422064766","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422064766?lang=zh_cn&edition=full","pubTime":"2024-03-27 01:33","pubTimestamp":1711474419,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日01时33分，Abcellera Biologics Inc.股票出现波动，股价急速跳水5.02%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一种抗体发现和开发引擎，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者。借助集成的 AbCelera 平台，公司的专家搜索范围广泛的不同抗体，以快速选择最有效和可开发的先导物，并建立合作伙伴以取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270133407a4f3a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270133407a4f3a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4535","ABCL"],"gpt_icon":0},{"id":"2418635007","title":"Abcellera Biologics Inc.盘中异动 早盘急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418635007","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418635007?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:38","pubTimestamp":1710164290,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时38分，Abcellera Biologics Inc.股票出现异动，股价大幅拉升5.03%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一种抗体发现和开发引擎，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者。借助集成的 AbCelera 平台，公司的专家搜索范围广泛的不同抗体，以快速选择最有效和可开发的先导物，并建立合作伙伴以取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121381187e77c60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121381187e77c60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4535","ABCL"],"gpt_icon":0},{"id":"2414801430","title":"Abcellera Biologics Inc盘中异动 早盘大幅上涨5.03%报5.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414801430","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414801430?lang=zh_cn&edition=full","pubTime":"2024-02-27 23:35","pubTimestamp":1709048137,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日23时35分，Abcellera Biologics Inc股票出现异动，股价快速上涨5.03%。Abcellera Biologics Inc股票所在的生物技术行业中，整体跌幅为0.42%。Abcellera Biologics Inc公司简介：AbCelera Biologics Inc 是一种抗体发现和开发引擎，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者。借助集成的 AbCelera 平台，公司的专家搜索范围广泛的不同抗体，以快速选择最有效和可开发的先导物，并建立合作伙伴以取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240227233537861d8e30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240227233537861d8e30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ABCL","BK4535"],"gpt_icon":0},{"id":"2413679564","title":"Abcellera Biologics Inc2023财年实现净利润-1.46亿美元，同比减少191.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413679564","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413679564?lang=zh_cn&edition=full","pubTime":"2024-02-24 00:21","pubTimestamp":1708705310,"startTime":"0","endTime":"0","summary":"12月31日，Abcellera Biologics Inc公布财报，公告显示公司2023财年净利润为-1.46亿美元，同比减少191.82%；其中营业收入为38.03百万美元，同比减少92.16%，每股基本收益为-0.51美元。从资产负债表来看，Abcellera Biologics Inc总负债2.40亿美元，其中短期债务6.16百万美元，资产负债比为6.21，流动比率为7.33。机构评级：截至2023年12月31日，当前有8家机构对Abcellera Biologics Inc目标价做出预测，其中目标均价为14.75美元，其中最低目标价为8.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022400215281aef4fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022400215281aef4fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL"],"gpt_icon":1},{"id":"2413267294","title":"Abcellera Biologics Inc盘中异动 早盘大幅跳水6.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413267294","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413267294?lang=zh_cn&edition=full","pubTime":"2024-02-21 22:30","pubTimestamp":1708525856,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日22时30分，Abcellera Biologics Inc股票出现波动，股价快速跳水6.59%。Abcellera Biologics Inc股票所在的生物技术行业中，整体涨幅为0.00%。Abcellera Biologics Inc公司简介：AbCelera Biologics Inc 是一种抗体发现和开发引擎，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者。借助集成的 AbCelera 平台，公司的专家搜索范围广泛的不同抗体，以快速选择最有效和可开发的先导物，并建立合作伙伴以取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212230567a455e14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212230567a455e14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","ABCL","BK4121"],"gpt_icon":0},{"id":"2411368351","title":"Abcellera Biologics Inc盘中异动 股价大跌5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411368351","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411368351?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:30","pubTimestamp":1707834654,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时30分，Abcellera Biologics Inc股票出现异动，股价快速跳水5.68%。Abcellera Biologics Inc股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大，Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃，换手率分别为291.70%、79.75%、29.32%，振幅较大的相关个股有Lisata Therapeutics Inc、Indaptus Therapeutics Inc、Nuvalent Inc，振幅分别为6.62%、6.51%、6.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322305487e6fdd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322305487e6fdd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4535","BK4121"],"gpt_icon":0},{"id":"2410825145","title":"Abcellera Biologics Inc盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410825145","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410825145?lang=zh_cn&edition=full","pubTime":"2024-02-12 23:05","pubTimestamp":1707750335,"startTime":"0","endTime":"0","summary":"北京时间2024年02月12日23时05分，Abcellera Biologics Inc股票出现波动，股价急速拉升5.09%。Abcellera Biologics Inc股票所在的生物技术行业中，整体跌幅为0.70%。Abcellera Biologics Inc公司简介：AbCelera Biologics Inc 是一种抗体发现和开发引擎，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者。借助集成的 AbCelera 平台，公司的专家搜索范围广泛的不同抗体，以快速选择最有效和可开发的先导物，并建立合作伙伴以取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240212230535861d4f41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240212230535861d4f41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4121","BK4535"],"gpt_icon":0},{"id":"2409272371","title":"Abcellera Biologics Inc盘中异动 临近午盘急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409272371","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409272371?lang=zh_cn&edition=full","pubTime":"2024-02-08 01:00","pubTimestamp":1707325203,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日01时00分，Abcellera Biologics Inc股票出现异动，股价快速跳水5.21%。Abcellera Biologics Inc股票所在的生物技术行业中，整体涨幅为1.16%。Abcellera Biologics Inc公司简介：AbCelera Biologics Inc 是一种抗体发现和开发引擎，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者。借助集成的 AbCelera 平台，公司的专家搜索范围广泛的不同抗体，以快速选择最有效和可开发的先导物，并建立合作伙伴以取得持久的成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208010004791015a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208010004791015a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4535","ABCL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abcellera.com","stockEarnings":[{"period":"1week","weight":-0.0481},{"period":"1month","weight":-0.0166},{"period":"3month","weight":-0.2326},{"period":"6month","weight":-0.4332},{"period":"1year","weight":-0.6153},{"period":"ytd","weight":-0.4799}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AbCellera Biologics Inc.于2012年11月8日根据不列颠哥伦比亚省商业公司法注册成立并开始经营活动。该公司从事的业务是在其医学研究和开发中综合运用多种复杂技术，以更快、更廉价、更有效地发掘抗体药物。自成立以来，公司一直致力于研发活动，以支持其目前的合作伙伴项目和未来的平台开发工作。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.031012},{"month":2,"riseRate":0,"avgChangeRate":-0.132842},{"month":3,"riseRate":0.25,"avgChangeRate":-0.046348},{"month":4,"riseRate":0,"avgChangeRate":-0.173736},{"month":5,"riseRate":0.75,"avgChangeRate":0.016324},{"month":6,"riseRate":0.25,"avgChangeRate":-0.025113},{"month":7,"riseRate":0.5,"avgChangeRate":-0.04194},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.041693},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.011885},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.042144},{"month":11,"riseRate":0.666667,"avgChangeRate":0.062052},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.014901}],"exchange":"NASDAQ","name":"AbCellera Biologics","nameEN":"AbCellera Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AbCellera Biologics(ABCL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供AbCellera Biologics(ABCL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"AbCellera Biologics,ABCL,AbCellera Biologics股票,AbCellera Biologics股票老虎,AbCellera Biologics股票老虎国际,AbCellera Biologics行情,AbCellera Biologics股票行情,AbCellera Biologics股价,AbCellera Biologics股市,AbCellera Biologics股票价格,AbCellera Biologics股票交易,AbCellera Biologics股票购买,AbCellera Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AbCellera Biologics(ABCL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供AbCellera Biologics(ABCL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}